Medicine and Dentistry
Human Papillomavirus Type 16
100%
COVID-19
94%
Immunity
94%
Association
82%
Prognosis
70%
Infection
68%
Patient
68%
DNA
65%
Human Immunodeficiency Virus
57%
Transplantation
52%
Human Tissue
47%
Personalized Medicine
47%
Medicine
47%
Disease Predisposition
47%
Medical Research
47%
Experience
47%
Breast Cancer
43%
Mouse Mammary Tumor Virus
37%
Woman
36%
Translational Research
29%
Analysis
29%
Consent
28%
T Cell
27%
Lesion
26%
Biopsy Technique
26%
Cervical Intraepithelial Neoplasia
26%
Protein
23%
Human Immunodeficiency Virus Infection
23%
Uterine Cervix Cytology
23%
Monotherapy
23%
Genetic Transcription
23%
Vitamin D
23%
Capture
23%
Virus Etiology
23%
Papillomavirus Infection
23%
Randomized Controlled Trial
23%
Antiretroviral Therapy
23%
Oncogene
23%
Emtricitabine
23%
Tenofovir Disoproxil
23%
Virus Like Agent
23%
T Lymphocyte Receptor
23%
Tissue Banking
23%
Kidney
23%
Consensus
23%
Hybrid
23%
Breast Cancer Cell Line
23%
Aptitude
23%
Lymphocyte Antigen Receptor
23%
Mitogenesis
23%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
75%
Breakthrough Infection
70%
Neutralization
68%
Omicron Coronavirus Variant
53%
COVID-19
39%
Antigen
23%
Neutralizing Antibody
23%
T Cell Receptor
23%
B Cell
17%
Infectious Disease
15%
Human Immunodeficiency Virus 1
11%
Lineages
9%
Vaccination
9%
Epitope
8%